Success Metrics

Clinical Success Rate

100.0%

Based on 12 completed trials

Completion Rate

100%(12/12)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

92%

Ph phase_2

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Phase 2Efficacy & side effects

1(7.7%)

N/ANon-phased studies

12(92.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(12)

Terminated(1)

Detailed Status

Completed12

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (7.7%)

N/A12 (92.3%)

Trials by Status

completed1292%

withdrawn18%

Recent Activity

0 active trials

Showing 5 of 13

completednot_applicable

Clinical Trials (13)

Showing 13 of 13 trials

NCT02962869Not Applicable

Human Photoallergy Test (824/2016)

Completed

NCT02751541Not Applicable

Human Phototoxicity Test

Completed

NCT02751372Not Applicable

18794 - Human Photo Toxicity Test

Completed

NCT02750488Not Applicable

18793 - Human Photoallergy Test

Completed

NCT02962856Not Applicable

Human Phototoxicity Test (823/2016)

Completed

NCT02750475Not Applicable

Human Phototoxicity Test

Completed

NCT02750449Not Applicable

Human Photoallergy Test

Completed

NCT02751463Not Applicable

18850 - Human Photoallergy Test

Completed

NCT02751515Not Applicable

Human Photoallergy Test

Completed

NCT02823483Not Applicable

18348-Human Phototoxicity Test

Completed

NCT02823496Not Applicable

18349-Human Photoallergy Test

Completed

NCT02751567Not Applicable

18776 - Human Photoallergy Test

Withdrawn

NCT00980135Phase 2

Sinecort Pilot Efficacy Study

Completed

All 13 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 13